|
|||||
|
|
| 药物性肝损伤 | |
| 引用本文： | 任美欣,孟庆华. 药物性肝损伤[J]. 临床荟萃, 2016, 31(7): 713. DOI: 10.3969/j.issn.1004-583X.2016.07.005 |
| 作者姓名： | 任美欣 孟庆华 |
| 作者单位： | 首都医科大学附属北京佑安医院 重症肝病科，北京100069 |
| 摘 要： | 药物性肝损伤(DILI)是引发肝病的重要原因之一。随着药物种类越来越多，应用日益广泛，DILI的发生率逐年上升，已成为一个严重的公共卫生问题。因此，了解药物性肝损伤的病因、发病机制、临床特征、诊断、治疗等尤为重要，本文就其中的一些研究进展做一简要综述。 |
| 关 键 词： | 药物性肝损伤 生物学标记 疾病特征 |
Drug induced liver injury |
|
| Ren Meixin,Meng Qinghua. Drug induced liver injury[J]. Clinical Focus, 2016, 31(7): 713. DOI: 10.3969/j.issn.1004-583X.2016.07.005 | |
| Authors: | Ren Meixin Meng Qinghua |
| Affiliation: | Department of Liver Disease and Severe Medicine，Beijing Youan Hospital Capital Medical University， Beijing 100069， China |
| Abstract: | Drug induced liver injury (DILI) is one of the important causes of liver disease. With more and more types of drugs are used widely， the incidence of DILI raiseds year by year， which has become a serious public health problem. Therefore， it is very important to understand the etiology， pathogenesis， clinical features， diagnosis and treatment of DILI. This paper makes a brief summary of some research progress. |
| Keywords: | drug induced liver injury；biological markers disease attributes |
| 本文献已被 CNKI 等数据库收录！ | |
| 点击此处可从《临床荟萃》浏览原始摘要信息 | |
| 点击此处可从《临床荟萃》下载全文 | |